Cyfuse Biomedical K.K. 4892Short Interest

No institution currently reports a short position of 0.5% or more in Cyfuse Biomedical K.K. (4892). The last disclosure was on 2026-08-17 (UBS AG, 0.49%).

Growth Market(Domestic) Pharmaceutical Pharmaceutical
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
1357 reports

Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It excludes 2 institutions whose last report is more than a year old (1.80% in total). It also excludes 11 institutions that fell below 0.5%. How estimates are calculated

Disclosure History Summary

First disclosure2022-12-07
Latest disclosure2026-08-17 (UBS AG, 0.49%)
Reporting institutions13 firms (1357 reports)
Peak estimated short interest18.49% (2023-08-03, 8 holders)

Short Interest Trend Last 5 years, by institution, % of shares outstanding

Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.

  • Morgan Stanley MUFG Securities Co., Ltd.
  • GOLDMAN SACHS INTERNATIONAL
  • UBS AG
  • JPM Securities Japan Co Ltd.
  • Barclays Capital Securities Ltd
  • Others
0.00%
Estimated short interest, 2026-11-18

Current Positions by Short Seller Latest report of each holder

Last report Short seller Position (shares) Ratio Change Status
2023-12-06 BNP Paribas Arbitrage SNC Position 75,400 shares Ratio 0.96% ▼0.13% −10,400 No report for 1+ year
2023-12-11 BNP Paribas Financial Markets formerly known as BNP Paribas Arbitrage SNC Position 66,200 shares Ratio 0.84% ▼0.12% No report for 1+ year
2026-08-17 UBS AG Position 49,600 shares Ratio 0.49% ▼0.01% −1,600 Below 0.5%
2026-07-17 Barclays Capital Securities Ltd Position 49,500 shares Ratio 0.49% ▼0.02% −2,000 Below 0.5%
2023-12-19 BNP Paribas Financial Markets SNC formerly known as BNP Paribas Arbitrage SNC Position 39,000 shares Ratio 0.49% ▼0.10% −7,300 Below 0.5%
2025-03-05 Pi Radians Capital Inc. Position 40,200 shares Ratio 0.49% ▼0.04% −3,600 Below 0.5%
2025-05-16 BNP Paribas Financial Markets SNC Position 41,500 shares Ratio 0.49% ▼0.01% −400 Below 0.5%
2025-04-04 Citigroup Global Markets Limited Position 39,800 shares Ratio 0.48% ▼0.03% −2,100 Below 0.5%
2025-06-10 MERRILL LYNCH INTERNATIONAL Position 39,700 shares Ratio 0.47% ▼0.03% −2,300 Below 0.5%
2025-08-26 JPM Securities Japan Co Ltd. Position 43,500 shares Ratio 0.47% ▼0.12% −11,200 Below 0.5%
2026-06-08 GOLDMAN SACHS INTERNATIONAL Position 47,100 shares Ratio 0.46% ▼0.13% −12,900 Below 0.5%
2026-06-18 Nomura International plc Position 45,300 shares Ratio 0.44% ▼0.10% −9,400 Below 0.5%
2025-12-26 Morgan Stanley MUFG Securities Co., Ltd. Position 35,400 shares Ratio 0.36% ▼0.14% −12,900 Below 0.5%

Disclosure History 1357 in total

Trade date Short seller Position (shares) Ratio Change Note
2026-08-17 UBS AG Position 49,600 shares Ratio 0.49% ▼0.01% −1,600 Below 0.5%
2026-07-21 UBS AG Position 51,200 shares Ratio 0.50% ▲0.01% +900 —
2026-07-17 Barclays Capital Securities Ltd Position 49,500 shares Ratio 0.49% ▼0.02% −2,000 Below 0.5%
2026-07-16 Barclays Capital Securities Ltd Position 51,500 shares Ratio 0.51% ▲0.02% +1,200 —
2026-07-08 Barclays Capital Securities Ltd Position 50,300 shares Ratio 0.49% ▼0.01% −600 Below 0.5%
2026-07-07 Barclays Capital Securities Ltd Position 50,900 shares Ratio 0.50% ▲0.03% +3,300 —
2026-07-02 Barclays Capital Securities Ltd Position 47,600 shares Ratio 0.47% ▼0.03% −3,000 Below 0.5%
2026-06-24 UBS AG Position 50,300 shares Ratio 0.49% ▼0.09% −8,500 Below 0.5%
2026-06-24 Barclays Capital Securities Ltd Position 50,600 shares Ratio 0.50% ▲0.03% +2,300 —
2026-06-22 Barclays Capital Securities Ltd Position 48,300 shares Ratio 0.47% ▼0.05% −4,200 Below 0.5%
2026-06-19 Barclays Capital Securities Ltd Position 52,500 shares Ratio 0.52% ▲0.10% +14,300 —
2026-06-18 Nomura International plc Position 45,300 shares Ratio 0.44% ▼0.10% −9,400 Below 0.5%
2026-06-12 Nomura International plc Position 54,700 shares Ratio 0.54% ▼0.06% −5,900 —
2026-06-09 UBS AG Position 58,800 shares Ratio 0.58% ▼0.02% −1,800 —
2026-06-08 Nomura International plc Position 60,600 shares Ratio 0.60% ▲0.11% +11,034 —
2026-06-08 GOLDMAN SACHS INTERNATIONAL Position 47,100 shares Ratio 0.46% ▼0.13% −12,900 Below 0.5%
2026-06-05 UBS AG Position 60,600 shares Ratio 0.60% ▲0.01% +100 —
2026-06-05 Nomura International plc Position 49,566 shares Ratio 0.49% ▼0.02% −2,034 Below 0.5%
2026-06-04 UBS AG Position 60,500 shares Ratio 0.59% ▼0.01% −300 —
2026-06-03 UBS AG Position 60,800 shares Ratio 0.60% ▲0.03% +2,700 —
2026-06-03 Nomura International plc Position 51,600 shares Ratio 0.51% ▼0.14% −14,265 —
2026-06-02 Nomura International plc Position 65,865 shares Ratio 0.65% ▲0.09% +9,065 —
2026-05-29 Nomura International plc Position 56,800 shares Ratio 0.56% ▼0.07% −6,800 —
2026-05-28 Nomura International plc Position 63,600 shares Ratio 0.63% ▲0.05% +4,900 —
2026-05-26 Nomura International plc Position 58,700 shares Ratio 0.58% ▲0.11% +11,300 —
2026-05-26 GOLDMAN SACHS INTERNATIONAL Position 60,000 shares Ratio 0.59% ▼0.07% −7,300 —
2026-05-21 Nomura International plc Position 47,400 shares Ratio 0.46% ▼0.13% −12,600 Below 0.5%
2026-05-20 UBS AG Position 58,100 shares Ratio 0.57% ▲0.16% +18,900 —
2026-05-20 Nomura International plc Position 60,000 shares Ratio 0.59% ▲0.20% +13,800 —
2026-05-18 Nomura International plc Position 46,200 shares Ratio 0.45% ▼0.06% −5,300 Below 0.5%

Shorted Stocks in the Same Industry Pharmaceutical

Stock Estimated ratio Short sellers
GNI Group Ltd.2160 11.16% 7 firms
Oncolys BioPharma Inc.4588 10.35% 7 firms
HEALIOS K.K.4593 10.20% 5 firms
SymBio Pharmaceuticals Limited4582 9.46% 7 firms
Nxera Pharma Co.,Ltd.4565 7.35% 5 firms

Related Stocks Same TSE 33 sector